D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 99 Citations 36,903 352 World Ranking 3865 National Ranking 2189

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Major depressive disorder
  • Psychiatry

Carlos A. Zarate mainly focuses on Antidepressant, Bipolar disorder, Major depressive disorder, Ketamine and Anesthesia. His studies deal with areas such as NMDA receptor, Antagonist, Mood disorders, Riluzole and Pharmacology as well as Antidepressant. His study in Bipolar disorder is interdisciplinary in nature, drawing from both Internal medicine and Lithium.

His Major depressive disorder study is concerned with the field of Depression as a whole. His Ketamine research is multidisciplinary, incorporating elements of Hydroxynorketamine, Bioinformatics, Major depressive episode, Electroconvulsive therapy and Dissociative. His study looks at the intersection of Anesthesia and topics like Randomized controlled trial with Lanicemine.

His most cited work include:

  • A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression (2287 citations)
  • Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors (852 citations)
  • NMDAR inhibition-independent antidepressant actions of ketamine metabolites (770 citations)

What are the main themes of his work throughout his whole career to date?

Carlos A. Zarate mostly deals with Major depressive disorder, Ketamine, Antidepressant, Bipolar disorder and Psychiatry. Carlos A. Zarate is exploring Major depressive disorder as part of his Depression and Neuroscience and Major depressive disorder studies. His Ketamine study is concerned with the larger field of Anesthesia.

His studies in Antidepressant integrate themes in fields like NMDA receptor, Pharmacology, Riluzole and Monoaminergic. Carlos A. Zarate interconnects Internal medicine, Lithium and Mood disorders in the investigation of issues within Bipolar disorder. In the field of Psychiatry, his study on Anxiety and Mood overlaps with subjects such as Suicidal ideation and Suicide prevention.

He most often published in these fields:

  • Major depressive disorder (32.03%)
  • Ketamine (31.34%)
  • Antidepressant (29.95%)

What were the highlights of his more recent work (between 2017-2021)?

  • Ketamine (31.34%)
  • Antidepressant (29.95%)
  • Major depressive disorder (32.03%)

In recent papers he was focusing on the following fields of study:

Ketamine, Antidepressant, Major depressive disorder, Depression and Pharmacology are his primary areas of study. His Ketamine study is within the categories of Anesthesia and Neuroscience. He combines subjects such as Metabotropic glutamate receptor, Glutamatergic, Long-term potentiation, Mood disorders and Monoaminergic with his study of Antidepressant.

His Major depressive disorder research incorporates themes from Bipolar disorder, Internal medicine, Crossover study and Rating scale. In general Depression study, his work on Esketamine often relates to the realm of Suicidal ideation, thereby connecting several areas of interest. His work investigates the relationship between Pharmacology and topics such as Hydroxynorketamine that intersect with problems in Pharmacokinetics and Metabotropic glutamate receptor 2.

Between 2017 and 2021, his most popular works were:

  • Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group (306 citations)
  • Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms (267 citations)
  • Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects (106 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Major depressive disorder
  • Psychiatry

Carlos A. Zarate focuses on Major depressive disorder, Ketamine, Antidepressant, Pharmacology and Crossover study. His Major depressive disorder study incorporates themes from Bipolar disorder, Internal medicine, Clinical psychology and Rating scale. His Ketamine study improves the overall literature in Anesthesia.

His Antidepressant study is concerned with Depression in general. His Depression research is under the purview of Psychiatry. His research in Pharmacology intersects with topics in NMDA receptor, Hydroxynorketamine, Psychotomimetic, Metabolite and Gamma power.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression

Carlos A. Zarate;Jaskaran B. Singh;Paul J. Carlson;Nancy E. Brutsche.
Archives of General Psychiatry (2006)

3084 Citations

Cellular Mechanisms Underlying the Antidepressant Effects of Ketamine: Role of α-Amino-3-Hydroxy-5-Methylisoxazole-4-Propionic Acid Receptors

Sungho Maeng;Carlos A. Zarate;Jing Du;Robert J. Schloesser.
Biological Psychiatry (2008)

1053 Citations

NMDAR inhibition-independent antidepressant actions of ketamine metabolites

Panos Zanos;Ruin Moaddel;Patrick J. Morris;Polymnia Georgiou.
Nature (2016)

932 Citations

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

Gerard Sanacora;Carlos A. Zarate;John H. Krystal;Husseini K. Manji.
Nature Reviews Drug Discovery (2008)

906 Citations

A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg.
Archives of General Psychiatry (2010)

889 Citations

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

Carlos A. Zarate;Nancy E. Brutsche;Lobna Ibrahim;Jose Franco-Chaves.
Biological Psychiatry (2012)

663 Citations

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

Husseini K Manji;Jorge A Quiroz;Jonathan Sporn;Jennifer L Payne.
Biological Psychiatry (2003)

612 Citations

The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)

584 Citations

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate.
Archives of General Psychiatry (2002)

579 Citations

The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence

Mauricio Tohen;Carlos A. Zarate;John Hennen;Hari Mandir Kaur Khalsa.
American Journal of Psychiatry (2003)

560 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Carlos A. Zarate

Eduard Vieta

Eduard Vieta

University of Barcelona

Publications: 254

Roger S. McIntyre

Roger S. McIntyre

University Health Network

Publications: 145

Gin S Malhi

Gin S Malhi

University of Sydney

Publications: 135

João Quevedo

João Quevedo

The University of Texas Health Science Center at Houston

Publications: 133

Ross J. Baldessarini

Ross J. Baldessarini

Harvard University

Publications: 133

Michael Berk

Michael Berk

Deakin University

Publications: 132

Mauricio Tohen

Mauricio Tohen

University of New Mexico

Publications: 115

Kenji Hashimoto

Kenji Hashimoto

Chiba University

Publications: 105

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 97

Ronald S. Duman

Ronald S. Duman

Yale University

Publications: 88

Jair C. Soares

Jair C. Soares

The University of Texas Health Science Center at Houston

Publications: 82

Allan H. Young

Allan H. Young

South London and Maudsley NHS Foundation Trust

Publications: 81

Sanjay J. Mathew

Sanjay J. Mathew

Baylor College of Medicine

Publications: 80

Flávio Kapczinski

Flávio Kapczinski

McMaster University

Publications: 80

Lakshmi N. Yatham

Lakshmi N. Yatham

University of British Columbia

Publications: 77

John H. Krystal

John H. Krystal

Yale University

Publications: 74

Trending Scientists

Henk Sips

Henk Sips

Delft University of Technology

Kaushik Chakrabarti

Kaushik Chakrabarti

Microsoft (United States)

Amr Salahieh

Amr Salahieh

Shifamed

Stuart Lindsay

Stuart Lindsay

Arizona State University

Congjie Gao

Congjie Gao

Zhejiang University of Technology

Frans P.M. Cremers

Frans P.M. Cremers

Radboud University Nijmegen

Reed B. Wickner

Reed B. Wickner

National Institutes of Health

Dallas M. Swallow

Dallas M. Swallow

University College London

Christopher G. Burd

Christopher G. Burd

Yale University

Michael D. West

Michael D. West

Advanced Cell Technology (United States)

Yuichi Onda

Yuichi Onda

University of Tsukuba

Peter Droogers

Peter Droogers

International Water Management Institute

Hiroshi Yamashita

Hiroshi Yamashita

University of Occupational and Environmental Health Japan

T. Mark Doherty

T. Mark Doherty

GlaxoSmithKline (United Kingdom)

Stephen J. Sharp

Stephen J. Sharp

University of Cambridge

Jake M. Najman

Jake M. Najman

University of Queensland

Something went wrong. Please try again later.